Theratechnologies (THTX) Competitors $2.77 -0.15 (-5.14%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$2.75 -0.02 (-0.72%) As of 05/2/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock THTX vs. KURA, OPT, PRTA, URGN, STOK, MRVI, VERV, GHRS, MNMD, and SAGEShould you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include Kura Oncology (KURA), Opthea (OPT), Prothena (PRTA), UroGen Pharma (URGN), Stoke Therapeutics (STOK), Maravai LifeSciences (MRVI), Verve Therapeutics (VERV), GH Research (GHRS), Mind Medicine (MindMed) (MNMD), and Sage Therapeutics (SAGE). These companies are all part of the "pharmaceutical products" industry. Theratechnologies vs. Kura Oncology Opthea Prothena UroGen Pharma Stoke Therapeutics Maravai LifeSciences Verve Therapeutics GH Research Mind Medicine (MindMed) Sage Therapeutics Theratechnologies (NASDAQ:THTX) and Kura Oncology (NASDAQ:KURA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, community ranking, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation. Does the media favor THTX or KURA? In the previous week, Kura Oncology had 17 more articles in the media than Theratechnologies. MarketBeat recorded 19 mentions for Kura Oncology and 2 mentions for Theratechnologies. Kura Oncology's average media sentiment score of 0.59 beat Theratechnologies' score of 0.43 indicating that Kura Oncology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Theratechnologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Kura Oncology 4 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer THTX or KURA? Kura Oncology received 408 more outperform votes than Theratechnologies when rated by MarketBeat users. Likewise, 69.68% of users gave Kura Oncology an outperform vote while only 54.39% of users gave Theratechnologies an outperform vote. CompanyUnderperformOutperformTheratechnologiesOutperform Votes3154.39% Underperform Votes2645.61% Kura OncologyOutperform Votes43969.68% Underperform Votes19130.32% Which has more risk and volatility, THTX or KURA? Theratechnologies has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, Kura Oncology has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Do analysts prefer THTX or KURA? Kura Oncology has a consensus price target of $23.89, indicating a potential upside of 269.23%. Given Kura Oncology's higher possible upside, analysts clearly believe Kura Oncology is more favorable than Theratechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Theratechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00Kura Oncology 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 2.92 Which has better earnings and valuation, THTX or KURA? Theratechnologies has higher revenue and earnings than Kura Oncology. Theratechnologies is trading at a lower price-to-earnings ratio than Kura Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTheratechnologies$88.67M1.44-$23.96M-$0.08-34.63Kura Oncology$53.88M9.70-$152.63M-$2.03-3.19 Is THTX or KURA more profitable? Kura Oncology has a net margin of 0.00% compared to Theratechnologies' net margin of -3.75%. Theratechnologies' return on equity of 0.00% beat Kura Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Theratechnologies-3.75% N/A -4.31% Kura Oncology N/A -44.09%-39.57% SummaryKura Oncology beats Theratechnologies on 9 of the 16 factors compared between the two stocks. Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THTX vs. The Competition Export to ExcelMetricTheratechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$127.37M$6.85B$5.55B$8.02BDividend YieldN/A2.95%5.09%4.22%P/E Ratio-27.707.4422.6918.83Price / Sales1.44257.63404.28106.72Price / CashN/A65.8538.1834.62Price / Book-6.166.576.794.33Net Income-$23.96M$143.14M$3.22B$247.97M7 Day PerformanceN/A3.48%3.38%3.18%1 Month Performance96.45%10.49%6.96%8.13%1 Year Performance116.41%-3.31%16.13%5.01% Theratechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THTXTheratechnologiesN/A$2.77-5.1%N/A+106.7%$127.37M$88.67M-27.70140Short Interest ↑KURAKura Oncology4.1489 of 5 stars$6.51+1.2%$25.50+291.7%-68.6%$525.87M$53.88M-2.76130Earnings ReportAnalyst ForecastNews CoveragePositive NewsOPTOpthea0.7957 of 5 stars$3.41+7.2%$1.33-60.9%+2.7%$524.84M$87,666.000.008News CoverageGap UpPRTAProthena3.4913 of 5 stars$9.65-0.5%$55.00+469.9%-61.4%$519.43M$135.16M-4.20130Upcoming EarningsInsider TradeNews CoverageURGNUroGen Pharma4.3061 of 5 stars$11.26+14.1%$32.86+191.8%-19.3%$519.02M$90.40M-3.57200Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeSTOKStoke Therapeutics3.4002 of 5 stars$9.47-3.0%$24.67+160.5%-17.6%$517.03M$36.56M-4.51100Upcoming EarningsMRVIMaravai LifeSciences4.0478 of 5 stars$2.01-2.0%$6.34+215.6%-76.5%$511.22M$259.19M-1.23610Upcoming EarningsOptions VolumeVERVVerve Therapeutics3.7445 of 5 stars$5.73-0.5%$25.75+349.4%-15.6%$508.80M$32.33M-2.33110Positive NewsGHRSGH Research1.8076 of 5 stars$9.40-1.4%$30.86+228.3%+1.8%$489.06MN/A-11.9010News CoverageMNMDMind Medicine (MindMed)2.3665 of 5 stars$6.36+2.1%$25.11+294.8%-27.2%$479.34MN/A-2.8140Upcoming EarningsNews CoveragePositive NewsSAGESage Therapeutics3.8769 of 5 stars$7.77-0.3%$8.81+13.4%-44.3%$477.71M$41.24M-1.18690Earnings ReportAnalyst UpgradeAnalyst RevisionNews Coverage Related Companies and Tools Related Companies KURA Competitors OPT Competitors PRTA Competitors URGN Competitors STOK Competitors MRVI Competitors VERV Competitors GHRS Competitors MNMD Competitors SAGE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THTX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
